Showing results (1241-1250 of 2,640) with videos related to
Sort By:
Pageof 264
Oncology Research|April 7, 2025
ERLNs augment simultaneous delivery of GFSV into PC-3 cells: Influence of drug combination on SDH, GPX-4, 5α-RD, and cytotoxicityRiyad F Alzhrani, Lama Binobaid, Abdulaziz A Aloraini, et al.Oncology Research|April 7, 2025
COPB2 promotes hepatocellular carcinoma progression through regulation of YAP1 nuclear translocationBiao Wu, Xianlin Guo, Zhishi Wu, et al.Oncology Research|April 7, 2025
The role of glutathione peroxidase 4 in the progression, drug resistance, and targeted therapy of non-small cell lung cancerJiaheng Wei, Liangming ZhuOncology Research|March 20, 2025
Terpinen-4-ol suppresses proliferation and motility of cutaneous squamous cell carcinoma cells by enhancing calpain-2 expressionDongyun Rong, Yushen Su, Zhirui Zeng, et al.Oncology Research|March 20, 2025
Ultrasound genomics related mitochondrial gene signature for prognosis and neoadjuvant chemotherapy resistance in triple negative breast cancerHuafang Huang, Guilin Wang, Dongyun Zeng, et al.Oncology Research|March 20, 2025
Loss of TNFRSF21 induces cisplatin sensitivity in lung adenocarcinomaDaien Zhou, Haoyang Yuan, Yiwei Hu, et al.Oncology Research|March 20, 2025
CYB5D2 inhibits the malignant progression of hepatocellular carcinoma by inhibiting TGF-β expression and epithelial-mesenchymal transitionDong Jiang, Zhi Qi, Zhiying Xu, et al.Oncology Research|March 20, 2025
Retraction: miR-135a confers resistance to gefitinib in non-small cell lung cancer cells by upregulation of RAC1Oncology Research|June 3, 2024
PHLDA2 reshapes the immune microenvironment and induces drug resistance in hepatocellular carcinomaKun Feng, Hao Peng, Qingpeng Lv, et al.Oncology Research|July 26, 2024
Analysis of the role of dihydromyricetin derived from vine tea (Ampelopsis grossedentata) on multiple myeloma by activating STAT1/RIG-I axisWei Jiang, Mei ZhouPageof 264